查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1620368

阿奇霉素的全球市場規模:各類型，各流通管道，各地區，範圍及預測

Global Azithromycin Market Size By Type (Oral, Injectable, and Ophthalmic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

阿奇黴素市場規模及預測

2024年阿奇黴素市場規模為69.8億美元，預計到2031年將達到107.1億美元，2024年至2031年複合年增長率為3.5%。細菌感染盛行率的增加正在推動阿奇黴素市場的成長。阿奇黴素全球市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

全球阿奇黴素市場的定義

阿奇黴素是屬於抗菌抗生素的一類藥物。一種有助於治療細菌感染的抗生素。阿奇黴素通常以 Zithromax 或 Zmax 的名稱出售。在這些情況下，醫生可能會開立阿奇黴素來治療肺部、鼻竇、皮膚和其他身體部位的輕度至中度感染。它可以抵抗有害微生物的生長，並且可以對抗多種微生物，包括真桿菌科的一些微生物。

它是世界上最受歡迎的抗生素之一。它是世界上最受歡迎的抗生素之一。阿奇黴素注射劑用於治療結合細菌感染，如呼吸道疾病、肺炎或耳部感染。

阿奇黴素可能是源自片黴素的大環內酯類抗生素。阿奇黴素的作用是與微生物核醣體亞基結合，抑制大分子合成的易位步驟，並抑制細菌生長。用於治療呼吸道疾病、肺炎、性傳染病等微生物引起的感染及皮膚、耳朵的不同感染及不同代謝感染。它也用於治療真正的鳥細菌晚期 (MAC) 感染。

細菌感染盛行率不斷上升，因此阿奇黴素片劑作為仿製藥和名藥的便利性日益增加，是可能推動市場成長的主要因素。此外，趨勢支出的增加、阿奇黴素作為預防藥物的重要性的增加以及製藥公司為加速分析活動而增加的投資都是推動阿奇黴素市場擴張的因素。

阿奇黴素全球市場概況

細菌感染盛行率的增加正在推動阿奇黴素市場的擴張。阿奇黴素是世界上最受歡迎的抗生素。阿奇黴素非常經濟，並且已被證明比其他類似產品在身體組織中的保留時間更長。在阿奇黴素市場，各公司正在積極投資和研究新療法和新市場空白。

新冠肺炎 (COVID-19) 已觸及抗生素市場，並擾亂了全球處方藥輸送鏈。然而，一些抗生素最初用於治療 COVID-19，並被廣泛用於治療 COVID-19 的處方和研究。例如，2020 年 3 月，輝瑞公司公佈了在法國進行的冠狀病毒 (COVID-19) 超標試驗中濫用其阿奇黴素 (Zithromax) 藥物和 Plaquenil 的積極訊息。在 COVID-19大流行期間，對抗生素的需求龐大，這對抗生素研究市場產生了重大影響。

例如，抗生素已被批准用於預防愛滋病毒感染者的細菌感染。然而，在一段時間內，由於相關風險問題，監管機構對許多治療方法的否決限制了阿奇黴素市場的擴張。目前，阿奇黴素用於治療急性細菌性泌尿道感染、性潰瘍病、鼻竇炎、慢性阻塞性肺病細菌性加重、社區獲得性呼吸道疾病、咽炎、皮膚感染以及各種症狀。

如上所述，新興市場對阿奇黴素的需求正在顯著成長。中國、印度、巴西和墨西哥等新興市場對阿奇黴素的需求正在快速成長。這為在這個市場階段運作的藥品製造商提供了巨大的機會。

然而，長期服用阿奇黴素導致抗藥性細菌發生率增加，以及與阿奇黴素相關的副作用，如噁心、腹痛、腹瀉、心律不整、嚴重頭暈和眼部問題，是抑制市場的因素增長，是預測期內阿奇黴素市場的進一步挑戰。

目錄

第1章 阿奇霉素的全球市場:簡介

  • 市場概要
  • 調查範圍
  • 前提條件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的調查手法

  • 資料探勘
  • 檢驗
  • 主要採訪
  • 資料來源一覽

第4章 阿奇霉素的全球市場展望

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力分析模式
  • 價值鏈分析

第5章 阿奇霉素的全球市場:各類型

  • 概要
  • 口服劑
  • 注射劑
  • 其他

第6章 阿奇霉素的全球市場:各流通管道

  • 概要
  • 醫院藥局
  • 零售藥局
  • 其他

第7章 阿奇霉素的全球市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區
    • 南美
    • 中東·非洲

第8章 全球阿奇霉素市場:競爭情形

  • 概要
  • 各公司的市場排行榜
  • 主要的開發策略

第9章 企業簡介

  • CSPC Ouyi Pharmaceutical
  • Aurobindo Pharma
  • Gland Pharma
  • Wockhardt
  • Sandoz
  • Zydus Pharmaceuticals
  • Mylan
  • Teva
  • Akorn
  • Pfizer

第10章 相關調查

簡介目錄
Product Code: 11630

Azithromycin Market Size And Forecast

Azithromycin Market size was valued at USD 6.98 Billion in 2024 and is projected to reach USD 10.71 Billion by 2031 , growing at a CAGR of 3.5% from 2024 to 2031. The increasing prevalence of bacterial infection is driving the growth of the Azithromycin Market. The Global Azithromycin Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Azithromycin Market Definition

Azithromycin is a class of drugs, that belongs to antibacterials antibiotics. It is an antibiotic that helps in treating bacterial infections. It is normally sold beneath the whole names Zithromax and Zmax. A doctor might impose azithromycin to treat mild-to-moderate infections of the lungs, sinuses, skin, and different body elements. It will resist harmful microorganisms from growing and may fight a large variety of microorganisms, together with several within the eubacteria family.

Azithromycin may be a macrolide antibiotic used to treat bacterial infections. it's one of the world's most popular antibiotics. The injectable sort of azithromycin is employed to treat bound bacterial infections, like respiratory disease, pneumonia, or ear infections. injectable azithromycin is typically given as an infusion into a vein over 60 minutes.

Azithromycin may be a macrolide antibiotic that's derived from Pediamycin. It works by inhibiting the translocation step in macromolecule synthesis by binding to ribosomal subunits in microorganisms which ends with the inhibition of bacterial growth. It is used for the treatment of infections caused by microorganisms like respiratory disease, pneumonia, sexually transmitted diseases, and different infection of the attention, skin, ear, and different metabolism infections. It can be conjointly utilized in the treatment of true bacteria avium advanced (MAC) infection.

The rise in the prevalence of bacterial infections, and therefore the increasing handiness of azithromycin tablets as generic and name medicine are the key factors that may drive the market growth. Also, growing tending expenditure, increasing importance of azithromycin as a prophylactic agent, and an increase in the investment by pharmaceutical corporations to accelerate analysis activities are the factors that may expand the Azithromycin Market.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Azithromycin Market Overview

The increasing prevalence of bacterial infection is driving the expansion of the Azithromycin Market. Azithromycin is the world's most popular antibiotic. It is verified to be extraordinarily economical and capable of remaining within the body tissue longer than other similar varieties. Companies are investing and investigating considerably within the Azithromycin marketplace for a new treatment, gap due to new markets.

COVID-19 wedged the worldwide offer chain of prescription drugs, touching the antibiotics market. However, several antibiotics were at first used to treat COVID-19 and are widely prescribed and studied because of the COVID-19 remedy. For instance, in March 2020, Pfizer declared positive information for exploitation of its azithromycin (Zithromax) drug, together with Plaquenil, in an exceeding coronavirus (COVID-19) test performed in France. There was a large demand for antibiotics throughout the COVID-19 pandemic, that conjointly wedged the studied market of antibiotics.

For instance, authority approval for preventing bacterial infections in individuals with HIV. However, at constant times, authority disapproval for many therapies due to risk issues associated is restraining the expansion of the Azithromycin Market. At present, azithromycin is approved for acute bacterial urinary tract infection, venereal ulceration malady, sinusitis, bacterial exacerbations of chronic clogging pneumonic malady community-acquired respiratory disease, sore throat, skin infections, and different conditions.

There is a huge and growing demand from rising markets. The demand for azithromycin is growing quickly in rising markets like China, India, Brazil, and Mexico due to the increasing incidence of infectious diseases as well as rising incomes and increasing tending infrastructure. This presents a large chance for drugmakers in operation during this market phase.

However, an increase in the incidence of bacterial resistance due to long-run administration of azithromycin and the effects related to azithromycins like nausea, abdominal pain, diarrhea, irregular heartbeat, severe lightheadedness, and eye issues are the factors that may hinder the market growth and an additional challenge the Azithromycin Market within the forecast period.

Global Azithromycin Market Segmentation Analysis

The Global Azithromycin Market is segmented on the basis of Type, Distribution Channel, And Geography.

Azithromycin Market, By Type

  • Oral
  • Injectable
  • Ophthalmic

Based on Type, the market is segmented into Oral, Injectable, and Ophthalmic. The Oral segment is dominating the market with the highest market share and is expected to grow substantially and dominate the global market during the forecast period.

Azithromycin Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The Hospital Pharmacies component is witnessing the highest market share with strong market growth during the forecast period in the global market. The Segment centers on the standing and opportunity for significant application value, market share, and growth valuation of each application.

Azithromycin Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on Regional Analysis, the Global Azithromycin Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North America and Europe regions are dominating the Global Market with the highest market stake and are predicted to grow substantially and dominate the Global Azithromycin Market throughout the forecast period.

Key Players

  • The "Global Azithromycin Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Pfizer, Akorn, Teva, Mylan, Zydus Pharmaceuticals, Sandoz, Wockhardt, Gland Pharma, Aurobindo Pharma, and CSPC Ouyi Pharmaceutical, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation, Anke Hengyi
  • . Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL AZITHROMYCIN MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL AZITHROMYCIN MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porter Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL AZITHROMYCIN MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Oral
  • 5.3 Injectable
  • 5.4 Others

6 GLOBAL AZITHROMYCIN MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
  • 6.2 Hospital Pharmacies
  • 6.3 Retail Pharmacies
  • 6.4 Others

7 GLOBAL AZITHROMYCIN MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 The U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 The U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 The Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 The Middle East and Africa

8 GLOBAL AZITHROMYCIN MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 CSPC Ouyi Pharmaceutical
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Aurobindo Pharma
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Gland Pharma
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Wockhardt
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Sandoz
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Zydus Pharmaceuticals
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Mylan
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Teva
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Akorn
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Pfizer
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Related Research